NCT02818751View on ClinicalTrials.gov

Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2020

Conditions
Anxiety
Interventions
DRUG

Escitalopram

Patients being randomized to receive escitalopram.

OTHER

Placebo

Patients being randomized to receive placebo.

Trial Locations (1)

45219

University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience, Cincinnati

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Cincinnati

OTHER

NCT02818751 - Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety | Biotech Hunter | Biotech Hunter